Abstract:BACKGROUND & OBJECTIVE:Staphylococcal enterotoxin A (SEA) is one of the widely researched superantigens, which is prospective in antitumor therapy. However, its application is limited due to the toxicity. This study was conducted to prepare the nanoparticle-encapsulated SEA (NSEA) and to observe its influences on the T-cell subgroups and the antitumor effects in vivo. METHODS:NSEA was prepared by the interfacial polymerization method.BALB/c mice were divided into 3 groups (each group had 12 mice). After injection of 0.1 ml normal saline (NS I group), 0.1 ml 2 mg/L free SEA (SEA I group) and 0.1 ml 2 mg/L NSEA(NSEA I group), the changes of T-cell subgroups (CD4(+) and CD8(+)) were observed. The mice model bearing hepatocellular carcinoma H22 were injected with 0.1 ml NS(NS II group), 0.1 ml 2 mg/L free SEA(SEA II group), 0.1 ml 2 mg/L NSEA (NESA II group), then the tumor volume and the survival time were recorded. RESULTS:SEA and NSEA significantly improved the absolute number of CD4(+) and CD8(+) T cells (P< 0.01); while the proportion of CD4(+) to CD8(+) did not change (P >0.05). The numbers of CD4(+) and CD8(+) T cells in NSEA I group reached the peaks [(8.26+/-1.46) x 10(9)/L and (5.53+/-0.91) x 10(9)/L] at 72 hours. The absolute number of CD4(+) T cells in SEA I group reached the peak of (8.61+/-1.59) x 10(9)/L at 48 hours,and the absolute number of CD8(+) T cells reached the peak of (6.05+/-1.31) x 10(9)/L at 72 hours; both of them descended to normal level at 96 hours. The inhibition rates of SEA II group and NSEA II group were 58.9% and 50% and the percentages of life span increase were 167% and 169%, respectively. CONCLUSION:NSEA and SEA could induce the activation and proliferation of T cells in vivo but could not influence the proportion of CD4(+) and CD8(+) cells in the mice. The effects of NSEA were weaker but longer than that of SEA. This study demonstrated that NSEA has the sustained release effects and prolongs the effective time.

Effects of superantigen staphylococcal enterotoxin B and C-loaded dendritic cells on hepatocarcinoma HcaF

Effects of Dendritic Cells Induced by Superantigen Staphylococcal Enterotoxin B or Staphylococcal Enterotoxin C on T Lymphocytes

In Vitro Biological Activities of Transmembrane Superantigen Staphylococcal Enterotoxin A Fusion Protein

Long-Term Results of A Phase Ii Clinical Trial of Superantigen Therapy with Staphylococcal Enterotoxin C after Microwave Ablation in Hepatocellular Carcinoma

Antitumor Effect of Immunizations with Fusions of Dendritic and Hepatocellular Carcinoma Cells in Mice

Influence of Staphylococcal Enterotoxin A on Immunogenicity of Hepatocellular Carcinoma Cells

Research Progress on Antitumor Effect of Staphylococcal Enterotoxin B

[Influence of Nanoparticle-Encapsulated SEA on T-cell Subgroups and Its Antitumor Effect on Hepatoma].

Effect of Dendritic Cell-Based Immunotherapy on Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Antitumor effects of the fusion protein of transmembrane-staphylococcal enterotoxin A

Superantigen-fused T Cell Engagers for Tumor Antigen-Mediated Robust T Cell Activation and Tumor Cell Killing

The Killing Effects of Cytotoxic T Lymphocytes Stimulated by Specific Hafp-Derived Peptides on Hepatocellular Cancer Cells

A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma

Superantigen-Sea Gene Modified Tumor Vaccine for Hepatocellular Carcinoma: an in Vitro Study

A Study on Anti-Hepatocellular Carcinoma of Tumor-Infiltrating Lymphocyte Cytotoxicity Activated by Dendritic Cells Loaded with Hepatocellular Carcinoma Antigens

Preliminary Study on Anti-Tumor Effects of Superantigen Activated Human Lymphocytes Vaccine Against Glioma in SCID Mice

Antitumor Efficacy of Staphylococcal Enterotoxin A Liposomes in Vivo

Eliciting specific antitumor immunity against hepatocellular carcinoma in vitro by fusions of HCC patient-derived dendritic cells with HCC cells

High Potency and Specific Anti-Tumor Immunoreaction Induced by Dendritic Cells and Superantigen

Anti-tumor Effect of CTL Induced by Tumor Soluble Antigen and Superantigen SEC

Antitumor Efficacy of the Specific Cytotoxic T Lymphocytes Activated by Rat Dendritic Cells Loaded with Tumor Antigens to Kill Rat Hepatocellular Carcinoma Cells in Vitro